Collectively, these findings demonstrate that dual inhibition of the PI3K/mTOR and MEK pathways results in significant suppression of markers associated with cell adhesion, motility, and extracellular matrix remodeling, underscoring the potential of combination therapy strategies in mitigating the invasive behavior of melanoma cells. This evidence concerns the gene MAP2K7 and melanoma.